Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib pilot trial in refractory arteriovenous malformations
2019-003573-26Phase 2Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trametinib in arteriovenous malformation (AVM), sponsored by Cliniques universitaires Saint-Luc. Primary endpoints: Efficacy and safety evaluation of trametinib, Doppler ultrasonography assessment and 3 more. Started Dec 2019; status: completed.
02
Drugs
trametinib
03
Conditions
arteriovenous malformation (AVM)
Beyond the preview
Go deeper on 2019-003573-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003573-26.